PharmaCyte Biotech, Inc.
PMCBHealthcare|Biotechnology|US
$0.36
-0.02 (-4.05%)
DCF Value
$2.22
Tangible Book / Share
$2.78
Cash / Share
$2.84
Analyst Consensus
Hold1 analysts
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Rating Trend
Jun 24
0 buy · 1 hold · 0 sell
Jul 24
0 buy · 1 hold · 0 sell
Aug 24
0 buy · 1 hold · 0 sell
Sep 24
0 buy · 1 hold · 0 sell
Oct 24
0 buy · 1 hold · 0 sell
Nov 24
0 buy · 1 hold · 0 sell
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| HC Wainwright & Co. | maintain | Neutral | Nov 8, 2021 |
Earnings History
Next report: Dec 16, 2026 · EPS est. $-0.06| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Sep 14, 2026 | $-0.54 | $-0.06 | — | — |
| Jul 1, 2026 | $-0.46 | $-0.06 | — | — |
| Mar 17, 2026 | $0.13 | $-0.06 | — | — |
| Dec 18, 2025 | $-0.32 | — | — | — |
| Sep 15, 2025 | $-0.09 | — | — | — |
| Aug 11, 2025 | $1.73 | — | — | — |
| Mar 17, 2025 | $-0.10 | — | — | — |
| Dec 13, 2024 | $-0.29 | — | — | — |